Variables affecting apolipoprotein B measurements in 3- to 5-day-old babies: a study of 4491 neonates
- PMID: 3110726
- DOI: 10.1203/00006450-198706000-00020
Variables affecting apolipoprotein B measurements in 3- to 5-day-old babies: a study of 4491 neonates
Abstract
To investigate the feasibility of establishing a neonatal screening program for familial type II hypercholesterolemia, we assayed apolipoprotein B (Apo B), using a radial immunodiffusion assay, in dried blood spot samples from 4491 consecutively born, 3- to 5-day-old neonates. We explored factors influencing levels at the time of sampling and factors associated with the handling of the dried blood spot samples before assay which could affect the assayed value. Assayed Apo B levels were distributed continuously and decreased with increasing delay and temperature of storage of the samples before assay. Female neonates had significantly higher mean Apo B levels than males (p less than 0.0001), with their respective means +/- SD being 0.246 +/- 0.085 g/liter (n = 2086) and 0.225 +/- 0.079 g/liter of whole blood (n = 2390). In both sexes mean Apo B levels were significantly lower in low birth weight (less than or equal to 2.5 kg) and in low gestational age (less than or equal to 36 wk) neonates. For neonates with birth weight greater than 2.5 kg and gestational age more than 36 wk, Apo B levels increased with increasing birth weight and gestational age. Sex, birth weight, and gestational age could account for 5.7% of the variability of Apo B. After adjustments for these variables, the neonate's age at sampling did not influence Apo B levels significantly. Apo B levels were not affected by different dietary regimens, whether breast-fed, formula-fed, or breast-fed with formula complement.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
A neonatal screening approach to the detection of familial hypercholesterolaemia and family-based coronary prevention.J Inherit Metab Dis. 1988;11 Suppl 1:87-90. doi: 10.1007/BF01800573. J Inherit Metab Dis. 1988. PMID: 3141689 Review.
-
Screening for familial hypercholesterolemia in 5000 neonates: a recall study.Pediatr Res. 1988 May;23(5):500-4. doi: 10.1203/00006450-198805000-00013. Pediatr Res. 1988. PMID: 3387172
-
Neonatal apo A-I, apo B, and apo(a) levels in dried blood spots in an Australian population.Pediatr Res. 1990 Nov;28(5):496-501. doi: 10.1203/00006450-199011000-00016. Pediatr Res. 1990. PMID: 2123979
-
Apolipoproteins A-I and B and the B/A-I ratio in the first year of life.Pediatr Res. 1991 Dec;30(6):544-9. doi: 10.1203/00006450-199112000-00010. Pediatr Res. 1991. PMID: 1805151
-
Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.J Intern Med. 2006 May;259(5):473-80. doi: 10.1111/j.1365-2796.2006.01645.x. J Intern Med. 2006. PMID: 16629853 Review.
Cited by
-
A neonatal screening approach to the detection of familial hypercholesterolaemia and family-based coronary prevention.J Inherit Metab Dis. 1988;11 Suppl 1:87-90. doi: 10.1007/BF01800573. J Inherit Metab Dis. 1988. PMID: 3141689 Review.
-
Analytical Validation of Familial Hypercholesterolemia Biomarkers in Dried Blood Spots.Int J Neonatal Screen. 2022 Feb 9;8(1):14. doi: 10.3390/ijns8010014. Int J Neonatal Screen. 2022. PMID: 35225936 Free PMC article.
-
Familial Hypercholesterolemia Biomarker Distribution in Dried Blood Spots.J Pediatr. 2023 Aug;259:113469. doi: 10.1016/j.jpeds.2023.113469. Epub 2023 May 12. J Pediatr. 2023. PMID: 37182660 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources